Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8820059 | Respiratory Medicine | 2017 | 23 Pages |
Abstract
The study showed that serum VAP-1 level increased with an increasing severity of obstruction in patients with stable COPD. This increase was associated with a reduced quality of life and increased severity of hypoxia. These results suggest that inhibiting serum VAP-1 level in COPD patients may be useful in managing the disease.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Mojtaba Amani, Naiemeh Ghadimi, Mohammad Reza Aslani, Hassan Ghobadi,